Pages that link to "Q28287576"
Jump to navigation
Jump to search
The following pages link to A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia (Q28287576):
Displaying 14 items.
- Treating Negative Symptoms in Schizophrenia: an Update (Q26744805) (← links)
- Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders (Q26765419) (← links)
- nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. (Q30362464) (← links)
- Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders (Q30372351) (← links)
- Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats (Q30391389) (← links)
- Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia (Q30428422) (← links)
- Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review. (Q34879435) (← links)
- Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker (Q37258840) (← links)
- Potential serotonergic agents for the treatment of schizophrenia (Q38635792) (← links)
- A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia. (Q39220948) (← links)
- Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled Trials (Q41687338) (← links)
- Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine. (Q47413993) (← links)
- Tropisetron and its targets in Alzheimer's disease (Q50612380) (← links)
- One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia (Q94459181) (← links)